Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.
Year: 2002
Type: article
Abstract: Familial combined hyperlipidaemia (FCH) was originally identified by Goldstein et al.1, Rose et al.2 and Nikkila and Aro3 in the early 1970s as a new inherited lipid disorder, characterized by multiple lipoprotein phenotypes and strongly associated with premature cardiovascular disease. At present, FCH is the most common inherited hyperlipidaemia in humans, affecting 1–3% of the population and up to 20% of patients with premature myocardial infarction. The genetic and metabolic basis of the disorder has not been defined4–6. This review discusses the different metabolic pathways in the pathogenesis of FCH with emphasis on the role of insulin resistance, adipose tissue metabolism and free fatty acids (FFA).
Source: Europe PMC (PubMed Central)
Institution: Radboud University Medical Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2994184924
